ImmunoMatrix, LLC is a seed-stage company focused on the commercialization of a proprietary platform technology that makes non-invasive delivery of large molecules through the skin possible. Based on preclinical proof of concept data, our patient-friendly, cost-effective skin patch can deliver molecules much larger than previously thought possible across the outer layer of skin, thereby serving as a platform for applications such as vaccinations, immunotherapies, and diagnostics.
Company’s Keywords:
transdermal delivery
<2
<
<2015